194 related articles for article (PubMed ID: 33722417)
1. The GOG partners: A program for industry sponsored clinical trials in gynecologic oncology within the GOG foundation.
Monk BJ; Coleman RL; Herzog TJ; Moore KN; O'Malley DM; Randall LM; Slomovitz BM; Eskander R; Pothuri B; Reese LL; Mannel RS; Copeland LJ
Gynecol Oncol; 2021 Jul; 162(1):203-209. PubMed ID: 33722417
[TBL] [Abstract][Full Text] [Related]
2. Report on NRG Oncology and the GOG Foundation.
Alvarez RD
Gynecol Oncol; 2015 Oct; 139(1):3-4. PubMed ID: 26325528
[No Abstract] [Full Text] [Related]
3. Joint ENGOT and GOG Foundation requirements for trials with industry partners.
Vergote I; Coleman RL; Pignata S; Bookman MA; Marth C; Herzog TJ; Gonzalez Martin A; Copeland LJ;
Int J Gynecol Cancer; 2019 Sep; 29(7):1094-1097. PubMed ID: 31320391
[No Abstract] [Full Text] [Related]
4. Progress in gynecologic cancer research: the Gynecologic Oncology Group experience.
Omura GA;
Semin Oncol; 2008 Oct; 35(5):507-21. PubMed ID: 18929149
[TBL] [Abstract][Full Text] [Related]
5. Joint ENGOT and GOG Foundation requirements for trials with industry partners.
Vergote I; Coleman RL; Pignata S; Bookman MA; Marth C; Herzog TJ; Gonzalez-Martin A; Copeland LJ; ;
Gynecol Oncol; 2019 Aug; 154(2):255-258. PubMed ID: 31331494
[No Abstract] [Full Text] [Related]
6. Inclusion, diversity, equity, and access (IDEA) in gynecologic cancer clinical trials: A joint statement from GOG foundation and Society of Gynecologic Oncology (SGO).
Pothuri B; Blank SV; Myers TK; Hines JF; Randall LM; O'Cearbhaill RE; Slomovitz BM; Eskander RN; Alvarez Secord A; Coleman RL; Walker JL; Monk BJ; Moore KN; O'Malley DM; Copeland LJ; Herzog TJ
Gynecol Oncol; 2023 Jul; 174():278-287. PubMed ID: 37315373
[No Abstract] [Full Text] [Related]
7. Paradigm shifts in gynecologic oncology.
Casarin J; Bogani G; Multinu F; Mariani A; Abu-Rustum NR; Ghezzi F; Ramirez PT
Int J Gynecol Cancer; 2021 Dec; 31(12):1617. PubMed ID: 34716176
[No Abstract] [Full Text] [Related]
8. Minority participation in Gynecologic Oncology Group (GOG) Studies.
Scalici J; Finan MA; Black J; Harmon MD; Nicolson W; Lankes HA; Brady WE; Rocconi RP
Gynecol Oncol; 2015 Aug; 138(2):441-4. PubMed ID: 26013697
[TBL] [Abstract][Full Text] [Related]
9. American Society of Clinical Oncology 2012 Annual Meeting: highlights from the gynecologic oncology track.
Tewari KS
Int J Gynecol Cancer; 2012 Nov; 22(9):1634-9. PubMed ID: 23095779
[TBL] [Abstract][Full Text] [Related]
10. Managed care in gynecologic oncology.
Cohen CJ; Ripley D
Curr Opin Obstet Gynecol; 1996 Aug; 8(4):325-8. PubMed ID: 8875047
[TBL] [Abstract][Full Text] [Related]
11. Gynecologic Oncology Group quality assurance audits: analysis and initiatives for improvement.
Blessing JA; Bialy SA; Whitney CW; Stonebraker BL; Stehman FB
Clin Trials; 2010 Aug; 7(4):390-9. PubMed ID: 20576671
[TBL] [Abstract][Full Text] [Related]
12. Quality assessment and assurance programs in the Gynecologic Oncology Group.
Stehman FB; Blessing JA; Fowler WC; Park RC
Obstet Gynecol; 1994 Dec; 84(6):1059-62. PubMed ID: 7970467
[TBL] [Abstract][Full Text] [Related]
13. Trends and geographic variation in women's representation as principal investigators (PI) in phase 3 gynecologic oncology clinical trials.
Jou J; Brodsky A; Charo L; Binder P; Saenz C; Eskander RN; McHale M; Plaxe S
Gynecol Oncol; 2021 Aug; 162(2):389-393. PubMed ID: 34099315
[TBL] [Abstract][Full Text] [Related]
14. Experience with the use of generalized data base management systems in cooperative group clinical trials (a project of the Gynecologic Oncology Group).
Blessing JA; Bundy BN; Reese PA; Priore RL
Control Clin Trials; 1987 Mar; 8(1):60-6. PubMed ID: 3568697
[TBL] [Abstract][Full Text] [Related]
15. Clinical needs for transgender men in the gynecologic oncology setting.
Stenzel AE; Moysich KB; Ferrando CA; Starbuck KD
Gynecol Oncol; 2020 Dec; 159(3):899-905. PubMed ID: 33004214
[TBL] [Abstract][Full Text] [Related]
16. Shaping the standard of care in ovarian cancer management: A review of Gynecologic Oncology Group (GOG)/NRG oncology clinical trials of the past twenty years.
DiSilvestro PA
Gynecol Oncol; 2019 Jun; 153(3):479-486. PubMed ID: 30905435
[TBL] [Abstract][Full Text] [Related]
17. Gynecologic Oncology Group (GOG) Report.
Alvarez RD
Gynecol Oncol; 2010 Nov; 119(2):181-2. PubMed ID: 20719372
[No Abstract] [Full Text] [Related]
18. The times they are a-changin' - Transformation of accreditation and certification in gynecologic oncology.
Alvarez RD; Fowler WC
Gynecol Oncol; 2017 May; 145(2):221-223. PubMed ID: 28256320
[No Abstract] [Full Text] [Related]
19. The journey to setting up a comprehensive gynecologic cancer service in Upper Egypt.
Abdelbadee A; Abou-Taleb H
Int J Gynecol Cancer; 2021 May; 31(5):789-790. PubMed ID: 33115792
[No Abstract] [Full Text] [Related]
20. Gynecologic oncology group strategies to improve timeliness of publication.
Bialy S; Blessing JA; Stehman FB; Reardon AM; Blaser KM
Clin Trials; 2013 Aug; 10(4):617-23. PubMed ID: 23794406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
